Drug: |
Nilotinib or Imatinib |
|||
---|---|---|---|---|
Trial: |
Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1) |
|||
Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Completed |
Mary Potter Oncology Center |
Principal Investigator: |
G. L. Cohen, MD |
---|---|
Contact: |
Erika Bosch +27-12-346-6701 ericka.bosch@mpoc.co.za |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Mary Potter Oncology Center Website: |
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.